Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson’s disease

Medicinal cannabis has shown promise for the symptomatic treatment of Parkinson’s disease (PD), but patient exposure to whole plant mixtures may be undesirable due to concerns around safety, consistency, regulatory issues, and psychoactivity. Identification of a subset of components responsible for...

Descripción completa

Detalles Bibliográficos
Autores principales: Morash, Michael G., Nixon, Jessica, Shimoda, Lori M. N., Turner, Helen, Stokes, Alexander J., Small-Howard, Andrea L., Ellis, Lee D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586206/
https://www.ncbi.nlm.nih.gov/pubmed/36278152
http://dx.doi.org/10.3389/fphar.2022.907579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586206/
https://www.ncbi.nlm.nih.gov/pubmed/36278152
http://dx.doi.org/10.3389/fphar.2022.907579

Ejemplares similares